×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Fairmount Funds Management LLC

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
COGTCogent Biosciences, Inc.Fairmount Funds Management LLC10% OwnerFeb 16, 2024Option Exercise$7.501,166,6668,749,9954,438,790Feb 16, 2024, 06:43 PM
DNTHDianthus Therapeutics, Inc. /DE/Fairmount Funds Management LLCDirectorJan 22, 2024Option Exercise$12.00834,33410,012,0082,762,837Jan 24, 2024, 07:02 PM
VRDNViridian Therapeutics, Inc.DEFairmount Funds Management LLCDirectorJan 22, 2024Buy$21.00476,1909,999,9901,839,954Jan 24, 2024, 06:44 PM
DNTHDianthus Therapeutics, Inc. /DE/Fairmount Funds Management LLCDirectorSep 26, 2023Buy$13.1530,000394,5001,903,833Sep 28, 2023, 05:09 PM
DNTHDianthus Therapeutics, Inc. /DE/Fairmount Funds Management LLCDirectorSep 19, 2023Buy$13.2030,000396,0001,873,833Sep 21, 2023, 04:23 PM
DNTHDianthus Therapeutics, Inc. /DE/Fairmount Funds Management LLCDirectorSep 13, 2023Buy$11.769,367110,1561,843,833Sep 13, 2023, 09:17 PM
DNTHDianthus Therapeutics, Inc. /DE/Fairmount Funds Management LLCDirectorSep 12, 2023Buy$10.8514,887161,5241,834,466Sep 13, 2023, 09:17 PM
APGEApogee Therapeutics, Inc.Fairmount Funds Management LLCDirectorJul 13, 2023Buy$17.00892,52915,172,993892,529Jul 17, 2023, 08:00 PM
APGEApogee Therapeutics, Inc.Fairmount Funds Management LLCDirectorJul 13, 2023Buy$17.001,992,73433,876,4781,992,734Jul 17, 2023, 08:00 PM
APGEApogee Therapeutics, Inc.Fairmount Funds Management LLCDirectorJul 13, 2023Buy$17.0055,913950,52155,913Jul 17, 2023, 08:00 PM
COGTCogent Biosciences, Inc.Fairmount Funds Management LLC10% OwnerJun 09, 2023Buy$12.00800,0009,600,0003,272,124Jun 13, 2023, 04:07 PM
VRDNViridian Therapeutics, Inc.DEFairmount Funds Management LLCDirectorAug 17, 2022Buy$23.50425,5319,999,9791,363,764Aug 19, 2022, 04:32 PM
COGTCogent Biosciences, Inc.Fairmount Funds Management LLC10% OwnerJun 16, 2022Buy$8.251,200,0009,900,0002,472,124Jun 21, 2022, 10:02 AM
VRDNViridian Therapeutics, Inc.DEFairmount Funds Management LLCDirectorSep 21, 2021Buy$11.00909,0009,999,000938,233Sep 23, 2021, 09:30 AM